U.S. Markets closed

FDA decision on Jazz Pharmaceuticals narcolepsy drug expected Wednesday

John George
FDA decision on Jazz Pharmaceuticals narcolepsy drug expected Wednesday

Jazz is seeking approval for solriamfetol for both excessive sleepiness in adult patients with narcolepsy and obstructive sleep apnea.